Healthways Inc. (HWAY) Stock Price Down 2.4%
Healthways Inc. (NASDAQ:HWAY)’s share price dropped 2.4% during trading on Thursday . The company traded as low as $11.78 and last traded at $11.79, with a volume of 194,217 shares. The stock had previously closed at $12.08.
HWAY has been the topic of a number of recent analyst reports. FBR & Co began coverage on Healthways in a research note on Friday, April 15th. They issued an “outperform” rating and a $16.00 price objective on the stock. Barrington Research dropped their price target on Healthways from $15.00 to $14.00 and set an “outperform” rating on the stock in a research note on Friday, April 29th. Jefferies Group reissued a “hold” rating and issued a $13.00 price target on shares of Healthways in a research note on Tuesday, May 3rd. Finally, Zacks Investment Research raised Healthways from a “sell” rating to a “hold” rating in a research note on Tuesday, May 3rd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $13.40.
The stock’s market capitalization is $425.37 million. The company’s 50 day moving average is $12.06 and its 200-day moving average is $11.53.
Healthways (NASDAQ:HWAY) last posted its quarterly earnings results on Thursday, April 28th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.06. The company earned $189.20 million during the quarter, compared to analyst estimates of $185.68 million. During the same quarter last year, the firm posted ($0.05) EPS. Healthways’s revenue was down .4% compared to the same quarter last year. Analysts expect that Healthways Inc. will post $0.24 EPS for the current year.
A number of institutional investors recently bought and sold shares of the company. BNP Paribas Arbitrage SA raised its position in Healthways by 37.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 80,127 shares of the company’s stock valued at $1,031,000 after buying an additional 21,702 shares during the last quarter. American Capital Management Inc. raised its position in Healthways by 4.0% in the fourth quarter. American Capital Management Inc. now owns 896,380 shares of the company’s stock valued at $11,536,000 after buying an additional 34,590 shares during the last quarter. Finally, Royce & Associates LLC raised its position in Healthways by 25.2% in the fourth quarter. Royce & Associates LLC now owns 796,704 shares of the company’s stock valued at $10,254,000 after buying an additional 160,500 shares during the last quarter.
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.